First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly ...

Atrial fibrillation, also known as AF or Afib, is one of the most common cardiovascular diseases. In fact, one in three ...

Social inequities in survival after atrial fibrillation have barely changed over the past 20 years. The results raise important questions about how the healthcare system can ensure equal access to ...

Jaypirca (pirtobrutinib) improved progression-free survival in treatment-naïve patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) when compared with bendamustine ...

Exercise is one of the best things we can do for a healthy heart. Yet research shows that endurance athletes have up to a ...

Obstructive sleep apnea and atrial fibrillation (AFib) are two conditions that share a potentially deadly link. Having one ...

Obstructive sleep apnea and atrial fibrillation are two conditions that share a potentially deadly link. Having one increases ...

The holidays are a season of joy, connection and celebration, but they can also be one of the most stressful times of the ...

Sen. John Fetterman was hospitalized Thursday after suffering injuries to his face in a fall due to a serious heart condition, ventricular fibrillation. This life-threatening condition is the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Atrial fibrillation (AF) affects more than 59 million ...

Sponsored content by guest writer Eric Van De Graaff, MD, a cardiologist with Methodist Physicians Clinic Oct 13, 2025 Oct 13, 2025 0 Dr. Eric Van De Graaff, a cardiologist at Methodist Physicians ...

Milestone Pharmaceuticals is advancing CARDAMYST, a self-administered nasal spray for PSVT, toward a pivotal FDA approval decision in mid-December. The firm faced setbacks this year with FDA CMC ...